 speciÔ¨Åc groups
of VADs were limited due to small study numbers in
some studies and the heterogeneous results. The authors
downgraded certainty in the evidence from high to
moderate because of risk of bias concerns, and further to
low because of imprecision. It is clear from this review
and multiple other meta-analyses,14-16,112 however, that
some of these drugs or supplements are better than the
others.
The